ETS signed an agreement to work with AstraZeneca.
ETS signed an agreement to work with AstraZeneca.

Ethiopian Thoracic Society signed an agreement to work with The Ethiopian Federal Ministry of Health and AstraZeneca, on the new Africa PUMUA Initiative, aimed at redefining asthma care in Africa.

The Initiative was designed in consultation and collaboration with government, healthcare societies, and respiratory health experts to strengthen local health systems and centers to improve pediatric and adult asthma management across both the public and private sectors.  The Africa PUMUA Initiative will support fundamental changes needed to advance clinical practice aligned to the Non-Communicable Disease (NCD) service decentralization program roll-out by the Ethiopian Federal Ministry of Health.  Globally, more than 339 million [1] people are living with asthma, with an estimated over 40 million people with asthma in Africa [2] . The World Health Organisation (WHO) cautions that over 80% of asthma-related deaths occur in low-and lower-middle-income countries [3].

As part of the partnership signed today, 27 January 2021,  with The Ethiopian Federal Ministry of Health and The Ethiopian Thoracic Society, AstraZeneca will provide 150 nebuliser machines to various hospitals within Ethiopia, as well as establish 47 nebulisation stations. The nebulisers will be allocated in consultation with the Ministry of Health and the Ethiopian Thoracic Society.

“It is estimated that more than 5 million people in Ethiopia are living with asthma, and to date there has been no national treatment guidelines for the diagnosis and treatment of Asthma. The Ethiopian Thoracic Society strongly believes that the implementation of the Africa PUMUA initiative will contribute significantly to the effective diagnosis and management of Asthma. The capacity building activities and the update and alignment of treatment guidelines and protocols for chronic asthma to GINA (Global Initiative for Asthma management) guidelines, will help to improve outcomes for asthma patients in Ethiopia. Cascading the treatment protocol and guidelines throughout the country will enable us provide standardised Asthma diagnosis and treatment in Ethiopia,” said Ethiopian Thoracic Society President, Dr Tewodros Haile Gebremariam

Barbara Nel, AstraZeneca Country President for African Cluster said: “ We are unwavering in our commitment to improve care for asthma patients across Africa.  People living with asthma should have the ability to live normal lives and deserve the best care. 

Dr Dereje Duguma , Ethiopian Federal Ministry of Health, said : Through this important Public-Private Partnerships with the AstraZeneca Pharmaceutical and the Ethiopian Thoracic Society we will bring immense transformation to Asthma care. 

Leave a Reply

Your email address will not be published. Required fields are marked *